XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.25.1

COMMON SHARES (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Equity [Abstract] |
Schedule of Black-Scholes model used in valuing the November Public Warrants and November Private Warrants | Schedule of Black-Scholes model used in valuing the November Public Warrants and November Private Warrants
|  | November 5, 2024 |
November Public Warrants: |  | Series A Public Warrants |  |  | Series B Public Warrants |
Closing Common Share price |  | $ | 1.455 |  |  | $ | 1.455 |
Term (years) |  |  | 4.5 |  |  |  | 2.0 |
Historic equity volatility |  |  | 67.43 | % |  |  | 67.13 | %
Risk-free rate |  |  | 4.14 | % |  |  | 4.20 | %
|  |  |  |  |  |  | March 31, 2025 |
November Private Warrants: |  |  |  |  |  |  |  | Series A Private Warrants |  |  | Series B Private Warrants |
Closing Common Share price |  |  |  |  |  |  |  |  |  | $ | 1.97 |  |  | $ | 1.97 |
Term (years) |  |  |  |  |  |  |  |  |  |  | 1.62 |  |  |  | 4.5 |
Historic equity volatility |  |  |  |  |  |  |  |  |  |  | 80.09 | % |  |  | 71.22 | %
Risk-free rate |  |  |  |  |  |  |  |  |  |  | 3.96 | % |  |  | 3.94 | %
The following table sets forth a summary of the changes in the fair value of the November Private Warrants liabilities | The following table sets forth a summary of the changes in the fair value of the November Private Warrants liabilities.
|  | November Private Warrants |
Fair value at issuance (November 13, 2024) |  | $ | 1,929 |
Change in fair value |  |  | 1,258 |
Fair value as of March 31, 2025 |  | $ | 3,187 |
The following primary inputs were used in the Black-Scholes model for valuing the January 2025 Warrants | The following primary inputs were used in the Black-Scholes model for valuing the January 2025 Warrants:
|  | Series A Public Warrants |  |  | Series B Public Warrants |
Closing Common Share price |  | $ | 2.25 |  |  | $ | 2.25 |
Term (years) |  |  | 2.5 |  |  |  | 4.0 |
Historic equity volatility |  |  | 73.18 | % |  |  | 73.36 | %
Risk-free rate |  |  | 4.23 | % |  |  | 4.31 | %
The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the nine months period: | The Company issued the following Common Shares under the Yorkville Equity Facility Financing Agreement during the nine months period:
|  | For The Three Months Ended March 31, |  |  | For The Nine Months Ended March 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Common Shares issued |  |  | 709,000 |  |  |  | 242,500 |  |  |  | 1,919,250 |  |  |  | 462,500 |
Gross funds received |  | $ | 1,286 |  |  | $ | 607 |  |  | $ | 3,111 |  |  | $ | 1,373 |
Market value of Common Shares Issued |  | $ | 1,328 |  |  | $ | 622 |  |  | $ | 3,191 |  |  | $ | 1,451 |
Loss on issuance |  | $ | 42 |  |  | $ | 15 |  |  | $ | 80 |  |  | $ | 78 |
Schedule Of Stock Option | Schedule Of Stock Option
|  |  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value |  |  | Weighted Average Remaining Life |
Balance, June 30, 2024 |  |  |  | 2,495,500 |  |  | $ | 4.78 |  |  |  |  |  |  |  |  |
Granted |  |  |  | 945,000 |  |  |  | 1.41 |  |  |  |  |  |  |  |  |
Exercised |  |  |  | (5,000 | ) |  |  | 1.40 |  |  |  |  |  |  |  |  |
Cancelled/expired |  |  |  | (362,500 | ) |  |  | 9.25 |  |  |  |  |  |  |  |  |
Balance, March 31, 2025 |  |  |  | 3,073,000 |  |  | $ | 3.17 |  |  | $ | 530 |  |  |  | 3.6 Years |
Schedule of warrant transactions | Schedule of warrant transactions
|  |  | Number of Warrants |  |  | Weighted Average Exercise Price |
Balance, June 30, 2024 |  |  |  | 18,563,561 |  |  | $ | 10.53 |
Granted |  |  |  | 12,490,252 |  |  |  | 2.00 |
Exercised |  |  |  | (230,000 | ) |  |  | 1.75 |
Expired |  |  |  | (1,303,118 | ) |  |  | 9.44 |
Balance, March 31, 2025 |  |  |  | 29,520,695 |  |  | $ | 7.12 |
As of March 31, 2025, the Company had outstanding exercisable Warrants, as follows | As of March 31, 2025, the Company had outstanding exercisable Warrants, as follows:
Number |  | Exercise Price |  | Expiry Date |
250,000 |  | $4.60 |  | September 1, 2025 |
413,432 |  | 3.54 |  | December 22, 2025 |
315,000 |  | 2.20 |  | June 24, 2026 |
1,442,090 |  | 1.75 |  | November 5, 2026 |
2,199,602 |  | 1.75 |  | November 13, 2026 |
615,385 |  | 3.25 |  | April 12, 2027 |
2,577,320 |  | 1.98 |  | August 2, 2027 |
15,666,626 |  | 11.50 |  | March 17, 2028 |
2,816,742 |  | 2.31 |  | September 17, 2028 |
1,288,660 |  | 2.05 |  | January 31, 2029 |
836,045 |  | 2.07 |  | November 5, 2029 |
1,099,793 |  | 2.07 |  | November 13, 2029 |
29,520,695 |  |  |  |  |
The following observable data points were used in calculating the fair value of the Private Warrants using a Black-Scholes pricing model | The Company classifies the Private Warrants as Level 2 instruments under the fair value hierarchy as inputs into our pricing model are based on observable data points. The following observable data points were used in calculating the fair value of the Private Warrants using a Black-Scholes pricing model:
Key Valuation Input |  | March 31, 2025 |  |  | June 30, 2024 |
Closing Common Share price |  | $1.97 |  |  | $1.73 |
Implied volatility of Public Warrants |  | 64.3 | % |  | 69.0 | %
Risk free rate |  | 3.88 | % |  | 4.45 | %
Dividend yield |  | 0 | % |  | 0 | %
Expected warrant life in years |  | 3.0 |  |  | 3.7 |
The change in the Private Warrants liability is presented below | The change in the Private Warrants liability is presented below:
|  | For the Nine Months Ended March 31, 2025 |
Fair value as of June 30, 2024 |  | $ | 1,353 |
Change in fair value |  |  | (680 | )
Fair value as of March 31, 2025 |  | $ | 673 |
The Company valued the Contingent Consent Warrants at $2,262 based on a Black-Scholes valuation with the following inputs: | The Company valued the Contingent Consent Warrants at $2,262 based on a Black-Scholes valuation with the following inputs:
Key Valuation Input |  | September 17, 2024
Closing Common Share price |  | $1.74
Term (years) |  | 4.0
Historic equity volatility |  | 67.14%
Risk-free rate |  | 3.44%

X
- Definition The element represents fair value assets and liability measured on recurring and nonrecurring basis of warrants table text block. + References No definition available. + Details
Name: | niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisOfWarrantsTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents fair value assets and liability measured on recurring and nonrecurring basis table text block. + References No definition available. + Details
Name: | niobf_FairValueAssetsAndLiabilityMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents schedule common shares under facility financing agreement table text block. + References No definition available. + Details
Name: | niobf_ScheduleCommonSharesUnderFacilityFinancingAgreementTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents schedule of changes in the fair value of the november private warrants table text block. + References No definition available. + Details
Name: | niobf_ScheduleOfChangesInTheFairValueOfTheNovemberPrivateWarrantsTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents schedule of changes in the fair value of the private warrants table text block. + References No definition available. + Details
Name: | niobf_ScheduleOfChangesInTheFairValueOfThePrivateWarrantsTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents schedule of outstanding exercisable warrants table text block. + References No definition available. + Details
Name: | niobf_ScheduleOfOutstandingExercisableWarrantsTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The element represents schedule of stock option roll forward table text block. + References No definition available. + Details
Name: | niobf_ScheduleOfStockOptionRollForwardTableTextBlock
Namespace Prefix: | niobf_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration